World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

Abstract

AUDIT OF DIFFERENT BACTERIAL MICRO-ORGANISM IN ACUTE EXACERBATION OF COPD

Dr. Azka Mushtaq*, Dr. Rameesha Hafeez and Dr. Rabia Khan

ABSTRACT

Objectives: To identify the frequency of bacterial pathogens in acute exacerbation of COPD. Materials & Methods: This cross sectional was conducted at Department of Pulmonology, Sheikh Zayed Hospital Rahim Yar Khan from August 2018 to February 2019 over the period of 6 months. A total of 162 patients of acute exacerbation of COPD of age 40-70 years and both genders were included. Patients with h/o concomitant bronchial carcinoma, pneumonia, chronic renal failure and chronic congestive failure were excluded. After taking informed written consent, a fresh sample of sputum was collected into a sterile container and was sent for culture and sensitivity. Each sample was examined and interpreted by consultant pathologist and identification of bacterial pathogens was noted. Results: Mean age was 57.10 ± 7.63 years. Out of the 162 patients, 112 (69.14%) were male and 50 (30.86%) were females with male to female ratio of 2.24:1. In this study, I have found the Streptococcus pneumoniae was the predominant organism isolated in 52 (32.10%) patients followed by Klebsiella pneumoniae in 38 (23.46%), Pseudomonas aeruginosa in 29 (17.90%), Moraxella catarrhalis in 23 (14.30%), Methicillin - Resistant Staphylococcus aureus in 19 (11.73%) and H. influenza in 01 (0.62%) patients of acute exacerbation COPD. Conclusion: This study concluded that streptococcus pneumoniae was the predominant organism isolated in patients of acute exacerbation of COPD followed by Klebsiella pneumoniae, Pseudomonas aeruginosa, Moraxella catarrhalis, Methicillin - Resistant Staphylococcus aureus and H. influenza.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR